Arkolith/Insider Trading/EWTX/Form 4

Koch Kevin

President and CEO, DirectorEdgewise Therapeutics, Inc. (EWTX) · full profile →Form 4 · filed May 7, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$70K
Net Open-Market Flow
-$70K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 2, 2025Sell(S)4K$16.45$70K21K
May 1, 2025Option exercise(M)10K—$025K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 1, 2025Option exercise(M)10K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-25-003658) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML